Interleukin-15-activated cytokine-induced killer cells may sustain remission in leukemia patients after allogeneic stem cell transplantation: feasibility, safety and first insights on efficacy

Títulos similares

• Expression of HLA-DR by mesenchymal stromal cells in the platelet lysate era: an obsolete release criterion for MSCs?
  por: Zyrafete Kuçi, et al.
  Publicado: (2024-01-01)
• CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties
  por: Selim Kuçi, et al.
  Publicado: (2010-04-01)
• Interleukin-15-activated cytokine-induced killer cells may sustain remission in leukemia patients after allogeneic stem cell transplantation: feasibility, safety and first insights on efficacy
  por: Eva Rettinger, et al.
  Publicado: (2016-04-01)
• Clonal analysis of multipotent stromal cells derived from CD271+ bone marrow mononuclear cells: functional heterogeneity and different mechanisms of allosuppression
  por: Zyrafete Kuçi, et al.
  Publicado: (2013-10-01)
• CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma
  por: Laura M. Moser, et al.
  Publicado: (2025-02-01)